Bio-Rad Laboratories (BIO) EBT Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bio-Rad Laboratories (BIO) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | -211.00 |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 1,575.00 |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 3,000.00 |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | -138.00 |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | -730.00 |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 30,357.00 |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -871.00 |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 2,904.00 |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | -1,462.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30,357.00 |
| Mar 31, 2026 | -12,903.00 |
| Dec 31, 2025 | -1,540.00 |
| Sep 30, 2025 | -3,557.00 |
| Jun 30, 2025 | 24,010.00 |
| Mar 31, 2025 | 63,816.00 |
| Dec 31, 2024 | 14,046.00 |
| Sep 30, 2024 | -53,970.00 |
| Jun 30, 2024 | -59,797.00 |
| Mar 31, 2024 | -9,808.00 |
| Dec 31, 2023 | -7,498.00 |
| Sep 30, 2023 | -23,854.00 |
| Jun 30, 2023 | -45,236.00 |
| Mar 31, 2023 | -14,469.00 |
| Dec 31, 2022 | 3,745.00 |
| Sep 30, 2022 | 2,934.00 |
| Jun 30, 2022 | -31,096.00 |
| Mar 31, 2022 | -82,740.00 |
| Dec 31, 2021 | -10,784.00 |
| Sep 30, 2021 | 60,809.00 |